title: Ifosfamide-based chemotherapy for recurrent or metastatic hemangiopericytoma.
authors.affiliation: Hacettepe University Institute of Oncology, Department of Medical Oncology, Ankara, Turkiye.
authors.forename: I
authors.initials: I
authors.lastname: Celik
authors.forename: N
authors.initials: N
authors.lastname: Başçil
authors.forename: S
authors.initials: S
authors.lastname: Yalçin
authors.forename: I H
authors.initials: IH
authors.lastname: Güllü
authors.forename: A
authors.initials: A
authors.lastname: Kars
authors.forename: I
authors.initials: I
authors.lastname: Barişta
authors.forename: G
authors.initials: G
authors.lastname: Tekuzman
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D005047:Etoposide / Q000008:administration & dosage; D005260:Female; D005542:Forearm; D006393:Hemangiopericytoma / Q000188:drug therapy* / Q000556:secondary; D006801:Humans; D007069:Ifosfamide / Q000008:administration & dosage; D008175:Lung Neoplasms / Q000188:drug therapy / Q000556:secondary; D008297:Male; D015080:Mesna / Q000008:administration & dosage; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy*; D016879:Salvage Therapy; D013899:Thoracic Neoplasms / Q000188:drug therapy*
chemical_list: D005047:Etoposide; D015080:Mesna; D007069:Ifosfamide